ArticleThe World Allergy Organization journal2025

Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers.

Yutong Sima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.